Brief: Galmed To Employ Onkai's Disruptive Artificial Intelligence (Ai) In Its Planned Phase 2A Clinical Trial In Psc

Eocene

10/07/2023 13:04

Galmed Pharmaceuticals Ltd  GLMD.O :
    * GALMED TO EMPLOY ONKAI'S DISRUPTIVE ARTIFICIAL
INTELLIGENCE (AI)
IN ITS PLANNED PHASE 2A CLINICAL TRIAL IN PSC
    * GALMED PHARMACEUTICALS LTD - TO EMPLOY ONKAI'S DISRUPTIVE
ARTIFICIAL INTELLIGENCE (AI) IN ITS PLANNED PHASE 2A CLINICAL
TRIAL IN PSC
    * GALMED PHARMACEUTICALS LTD -  CLINICAL DEVELOPMENT FOR PSC
IS
EXPECTED TO START WITH A PHASE 2A STUDY BEGINNING IN Q4 OF 2023

Source text for Eikon:  ID:nPn7kZ6ZMa 
Further company coverage:  GLMD.O